BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1231 related articles for article (PubMed ID: 8502296)

  • 1. Naturally occurring antibodies devoid of light chains.
    Hamers-Casterman C; Atarhouch T; Muyldermans S; Robinson G; Hamers C; Songa EB; Bendahman N; Hamers R
    Nature; 1993 Jun; 363(6428):446-8. PubMed ID: 8502296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of heavy and light chain sequences of conventional camelid antibodies from Camelus dromedarius and Camelus bactrianus species.
    Griffin LM; Snowden JR; Lawson AD; Wernery U; Kinne J; Baker TS
    J Immunol Methods; 2014 Mar; 405():35-46. PubMed ID: 24444705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains.
    Muyldermans S; Atarhouch T; Saldanha J; Barbosa JA; Hamers R
    Protein Eng; 1994 Sep; 7(9):1129-35. PubMed ID: 7831284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence and evolution of functional heavy-chain antibodies in Camelidae.
    Conrath KE; Wernery U; Muyldermans S; Nguyen VK
    Dev Comp Immunol; 2003 Feb; 27(2):87-103. PubMed ID: 12543123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of splice consensus signal is responsible for the removal of the entire C(H)1 domain of the functional camel IGG2A heavy-chain antibodies.
    Nguyen VK; Hamers R; Wyns L; Muyldermans S
    Mol Immunol; 1999 Jun; 36(8):515-24. PubMed ID: 10475606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Camel heavy-chain antibodies: diverse germline V(H)H and specific mechanisms enlarge the antigen-binding repertoire.
    Nguyen VK; Hamers R; Wyns L; Muyldermans S
    EMBO J; 2000 Mar; 19(5):921-30. PubMed ID: 10698934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The specific variable domain of camel heavy-chain antibodies is encoded in the germline.
    Nguyen VK; Muyldermans S; Hamers R
    J Mol Biol; 1998 Jan; 275(3):413-8. PubMed ID: 9466919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heavy-chain antibodies in Camelidae; a case of evolutionary innovation.
    Nguyen VK; Su C; Muyldermans S; van der Loo W
    Immunogenetics; 2002 Apr; 54(1):39-47. PubMed ID: 11976790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique single-domain antigen binding fragments derived from naturally occurring camel heavy-chain antibodies.
    Muyldermans S; Lauwereys M
    J Mol Recognit; 1999; 12(2):131-40. PubMed ID: 10398404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single domain antibodies: comparison of camel VH and camelised human VH domains.
    Riechmann L; Muyldermans S
    J Immunol Methods; 1999 Dec; 231(1-2):25-38. PubMed ID: 10648925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Camelising' human antibody fragments: NMR studies on VH domains.
    Davies J; Riechmann L
    FEBS Lett; 1994 Feb; 339(3):285-90. PubMed ID: 8112468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody repertoire development in camelids.
    De Genst E; Saerens D; Muyldermans S; Conrath K
    Dev Comp Immunol; 2006; 30(1-2):187-98. PubMed ID: 16051357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of heavy chain-only antibodies of Camelus bactrianus.
    Tillib SV; Vyatchanin AS; Muyldermans S
    Biochemistry (Mosc); 2014 Dec; 79(12):1382-90. PubMed ID: 25716733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single antibody domains as small recognition units: design and in vitro antigen selection of camelized, human VH domains with improved protein stability.
    Davies J; Riechmann L
    Protein Eng; 1996 Jun; 9(6):531-7. PubMed ID: 8862554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VH and VL region structure of antibodies that recognize the (NANP)3 dodecapeptide sequence in the circumsporozoite protein of Plasmodium falciparum.
    Anker R; Zavala F; Pollok BA
    Eur J Immunol; 1990 Dec; 20(12):2757-61. PubMed ID: 2125276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single domain camel antibodies: current status.
    Muyldermans S
    J Biotechnol; 2001 Jun; 74(4):277-302. PubMed ID: 11526908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The production and characterization of novel heavy-chain antibodies against the tandem repeat region of MUC1 mucin.
    Rahbarizadeh F; Rasaee MJ; Forouzandeh M; Allameh A; Sarrami R; Nasiry H; Sadeghizadeh M
    Immunol Invest; 2005; 34(4):431-52. PubMed ID: 16302687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rearrangement of the former VL interface in the solution structure of a camelised, single antibody VH domain.
    Riechmann L
    J Mol Biol; 1996 Jun; 259(5):957-69. PubMed ID: 8683598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic alterations in a case of alpha heavy chain disease leading to the generation of composite exons from the JH region.
    Bentaboulet M; Mihaesco E; Gendron MC; Brouet JC; Tsapis A
    Eur J Immunol; 1989 Nov; 19(11):2093-8. PubMed ID: 2513209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme.
    Desmyter A; Transue TR; Ghahroudi MA; Thi MH; Poortmans F; Hamers R; Muyldermans S; Wyns L
    Nat Struct Biol; 1996 Sep; 3(9):803-11. PubMed ID: 8784355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.